Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Oct 8, 2019 · 10-Q · 38 days after period end · 0001144204-19-047666
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Net Income | $274.32K | $17.69K |
| EPS Diluted | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Aug 31, 2019 · filed Oct 8, 2019 · 38 d after period end
